Matthew A. Fuller

1.5k total citations
52 papers, 835 citations indexed

About

Matthew A. Fuller is a scholar working on Psychiatry and Mental health, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Matthew A. Fuller has authored 52 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Matthew A. Fuller's work include Schizophrenia research and treatment (22 papers), Bipolar Disorder and Treatment (12 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Matthew A. Fuller is often cited by papers focused on Schizophrenia research and treatment (22 papers), Bipolar Disorder and Treatment (12 papers) and Pharmacological Effects and Toxicity Studies (6 papers). Matthew A. Fuller collaborates with scholars based in United States and Australia. Matthew A. Fuller's co-authors include George E. Jaskiw, P. Eric Konicki, George Jurjus, Anand P. Popli, Kenneth M. Shermock, Michelle Secic, Martha Sajatovic, Megan J. Ehret, Amy Grogg and Milton E. Strauss and has published in prestigious journals such as Annals of Internal Medicine, American Journal of Psychiatry and Anesthesiology.

In The Last Decade

Matthew A. Fuller

48 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew A. Fuller United States 18 570 167 131 95 82 52 835
I. Kurzthaler Austria 15 462 0.8× 126 0.8× 74 0.6× 97 1.0× 76 0.9× 31 704
Thomas J. Arndt United States 8 760 1.3× 171 1.0× 71 0.5× 147 1.5× 105 1.3× 8 1.1k
Randall J. Mack United States 15 404 0.7× 219 1.3× 84 0.6× 53 0.6× 133 1.6× 48 939
Maju Mathews United States 18 702 1.2× 300 1.8× 67 0.5× 204 2.1× 42 0.5× 73 1.0k
Mary Anne Dellva United States 16 831 1.5× 236 1.4× 295 2.3× 185 1.9× 41 0.5× 44 1.3k
Hiram Joseph Wildgust United Kingdom 13 436 0.8× 85 0.5× 90 0.7× 91 1.0× 87 1.1× 18 734
Robert L. Dufresne United States 14 487 0.9× 105 0.6× 158 1.2× 38 0.4× 146 1.8× 33 720
C. Barnas Austria 19 700 1.2× 197 1.2× 67 0.5× 65 0.7× 65 0.8× 61 1.2k
Ole Schjerning Denmark 9 285 0.5× 145 0.9× 168 1.3× 72 0.8× 117 1.4× 15 608
Stuart Kushner United States 14 1.0k 1.8× 119 0.7× 74 0.6× 250 2.6× 54 0.7× 19 1.2k

Countries citing papers authored by Matthew A. Fuller

Since Specialization
Citations

This map shows the geographic impact of Matthew A. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Fuller more than expected).

Fields of papers citing papers by Matthew A. Fuller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Fuller. The network helps show where Matthew A. Fuller may publish in the future.

Co-authorship network of co-authors of Matthew A. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Fuller. A scholar is included among the top collaborators of Matthew A. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Fuller. Matthew A. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brenner, Lisa A., Vincent F. Capaldi, Joseph I. Constans, et al.. (2025). Assessment and Management of Patients at Risk for Suicide: Synopsis of the 2024 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines. Annals of Internal Medicine. 178(3). 416–425.
2.
Schnurr, Paula P., Jessica L. Hamblen, Jonathan Wolf, et al.. (2024). The Management of Posttraumatic Stress Disorder and Acute Stress Disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine. 177(3). 363–374. 19 indexed citations
3.
Meng, Marie‐Louise, Jerome J. Federspiel, Matthew A. Fuller, et al.. (2023). Severe Maternal Morbidity According to Mode of Delivery Among Pregnant Patients With Cardiomyopathies. JACC Heart Failure. 11(12). 1678–1689. 4 indexed citations
4.
Fuller, Matthew A., et al.. (2023). Lived Experiences of Freshman College Students During a Pandemic. Journal of College Orientation Transition and Retention. 30(1). 1 indexed citations
5.
McQuaid, John R., Vincent F. Capaldi, Matthew A. Fuller, et al.. (2022). The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Annals of Internal Medicine. 175(10). 1440–1451. 31 indexed citations
6.
Jaskiw, George E., et al.. (2021). Development of Insomnia Associated With Different Formulations of Bupropion. The Primary Care Companion For CNS Disorders. 23(1). 5 indexed citations
7.
Fuller, Matthew A., Kenneth M. Shermock, Michelle Secic, et al.. (2009). Hospitalisation and resource utilisation in patients with schizophrenia following initiation of risperidone long-acting therapy in the Veterans Affairs Healthcare System. Journal of Medical Economics. 12(4). 317–324. 25 indexed citations
8.
Sajatovic, Martha, et al.. (2006). Risperidone in the treatment of bipolar mania. Neuropsychiatric Disease and Treatment. 2(2). 127–138. 11 indexed citations
9.
Jaskiw, George E., Per T. Thyrum, Matthew A. Fuller, Lisa A. Arvanitis, & Chiao Yeh. (2004). Pharmacokinetics of Quetiapine in Elderly Patients with Selected Psychotic Disorders. Clinical Pharmacokinetics. 43(14). 1025–1035. 26 indexed citations
10.
Fuller, Matthew A., et al.. (2004). Incorporating Clinical Monitoring Into Electronic Orders for Antipsychotics. Psychiatric Services. 55(4). 455–455. 1 indexed citations
11.
Fuller, Matthew A.. (2003). Art Meet Net, Net Meet Art. Project Muse (Johns Hopkins University). 1 indexed citations
12.
Fuller, Matthew A., Kenneth M. Shermock, Michelle Secic, & Amy Grogg. (2003). Comparative Study of the Development of Diabetes Mellitus in Patients Taking Risperidone and Olanzapine. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 1037–1043. 58 indexed citations
13.
Fuller, Matthew A., et al.. (2002). Phenylpropanolamine Appears Not to Promote Weight Loss in Patients With Schizophrenia Who Have Gained Weight During Clozapine Treatment. The Journal of Clinical Psychiatry. 63(4). 345–348. 36 indexed citations
14.
Konicki, P. Eric, et al.. (2001). Prefrontal cortical sulcal widening associated with poor treatment response to clozapine. Schizophrenia Research. 48(2-3). 173–176. 25 indexed citations
15.
Popli, Anand P., P. Eric Konicki, George Jurjus, Matthew A. Fuller, & George E. Jaskiw. (1997). Clozapine and Associated Diabetes Mellitus. The Journal of Clinical Psychiatry. 58(3). 108–111. 130 indexed citations
16.
Popli, Anand P., Matthew A. Fuller, & George E. Jaskiw. (1997). Sertraline and psychotic symptoms: a case series.. Annals of Clinical Psychiatry. 9(1). 15–17. 18 indexed citations
17.
Fuller, Matthew A., et al.. (1996). Selegiline in Treatment of Behavioral and Cognitive Symptoms of Alzheimer Disease. Annals of Pharmacotherapy. 30(10). 1122–1129. 15 indexed citations
18.
Fuller, Matthew A., et al.. (1996). Clozapine-Induced Urinary Incontinence: Incidence and Treatment With Ephedrine. The Journal of Clinical Psychiatry. 57(11). 514–518. 63 indexed citations
19.
Fuller, Matthew A., et al.. (1996). Clozapine Reduces Water-Drinking Behavior in Schizophrenic Patients With Polydipsia. Journal of Clinical Psychopharmacology. 16(4). 329–332. 23 indexed citations
20.
Fuller, Matthew A., et al.. (1991). Selegiline: Initial or Adjunctive Therapy of Parkinson's Disease?. DICP. 25(1). 36–40. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I. Kurzthaler Breakdown of academic impact, for papers by Thomas J. Arndt Breakdown of academic impact, for papers by Randall J. Mack Breakdown of academic impact, for papers by Maju Mathews Breakdown of academic impact, for papers by Mary Anne Dellva Breakdown of academic impact, for papers by Hiram Joseph Wildgust Breakdown of academic impact, for papers by Robert L. Dufresne Breakdown of academic impact, for papers by C. Barnas Breakdown of academic impact, for papers by Ole Schjerning Breakdown of academic impact, for papers by Stuart Kushner
Rankless by CCL
2026